Aprea Therapeutics, Inc. (APRE)
Operating Cash Flow Growth
4.50%
TTM · Period ending:
APRE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported4.50%period ending
Latest reported4.50%period ending
APRE TTM Cash from Operations YoY % (-102.50% → 4.50%)
Year-over-year change
High-resolution chart · PNG
APRE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 4.4981% | |
| 9.2966% | |
| 4.8852% | |
| 2.4767% | |
| 6.0329% | |
| -0.8951% | |
| -11.325% | |
| -10.6515% | |
| 19.3349% | |
| 41.6115% | |
| 51.3113% | |
| 60.0298% | |
| 48.7683% | |
| 28.9472% | |
| 33.6331% | |
| 23.4291% | |
| 28.0973% | |
| 33.3735% | |
| 13.4393% | |
| 0.1494% | |
| -34.1216% | |
| -58.4763% | |
| -63.4291% | |
| -103.2109% | |
| -102.5038% |